Found 22 matching trials
A Study to Assess Pharmacokinetic Exposures Following Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants PHASE1 The objective of this study is to compare pharmacokinetic exposures followi...
Show More Location
Clinical Pharmacology Of Miami /ID# 268219
Learn More & Join Trial
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease PHASE2 Crohn's disease (CD) is a long-lasting disease that causes severe inflammat...
Show More Location
Digestive Health Specialists /ID# 266216
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers PHASE1 Safety, tolerability and pharmacokinetics of single dose of BI 655066/ABBV-...
Show More Location
Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease PHASE3 The purpose of this study is to assess how well guselkumab works when compa...
Show More Location
Digestive Health Specialists of the Southeast
Learn More & Join Trial
A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease PHASE1 Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes...
Show More Location
Southern California Res. Ctr. /ID# 216257
Learn More & Join Trial
A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease PHASE2 The primary objective of the study was to investigate long-term safety of r...
Show More Location
MGG Group, Inc.Chevy Chase Clinical Research /ID# 155068
Learn More & Join Trial
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy PHASE4 With this prospective, randomized, multicentre, parallel group pragmatic no...
Show More Learn More & Join Trial
Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease. PHASE2 This study is a proof of concept, multi-center, randomized, double-blind, p...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study in Healthy Japanese and Caucasian Subjects to Assess the Pharmacokinetics, Safety and Tolerability of Risankizumab PHASE1 The main objective of this study is to assess the pharmacokinetics, safety,...
Show More Location
Altasciences Clinical Los Angeles, Inc /ID# 164197
Learn More & Join Trial
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease PHASE3 The study consists of 4 sub-studies, as follows:
* Sub-study 1 (Randomized...
Show More Status
Active Not Recruiting
Location
Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884
Learn More & Join Trial